
Gaudium IVF Q2 FY27 Revenue Up 17.9% to ₹37.4 Cr
Gaudium IVF and Women Health Limited announced its unaudited financial results for Q2 and H1 FY27. Revenue from operations for Q2 FY27 increased by 17.9% year-on-year to ₹37.4 crore (₹31.7 crore in Q2 FY26), driven by strong patient volumes and initial contributions from new hubs. For H1 FY27, revenue grew 14.7% to ₹56.8 crore (₹49.5 crore in H1 FY26). EBITDA for Q2 FY27 was ₹13.5 crore with a margin of 36.0%, impacted by one-off rollout expenses for two new IVF hubs in South Extension and Gurgaon. Profit After Tax (PAT) for Q2 FY27 stood at ₹9.4 crore, a marginal increase of 0.4% YoY. The company has successfully launched two new IVF hubs as part of its 19-centre expansion plan, with expectations of similar break-even trajectories as historical launches. The company operates 9 hubs and 28 spokes, maintaining a clinical pregnancy success rate of 62% on the first IVF attempt.
Key Highlights
- Q2 FY27 revenue rose 17.9% YoY to ₹37.4 Cr.
- H1 FY27 revenue increased 14.7% YoY to ₹56.8 Cr.
- Two new IVF hubs operational as part of expansion.
- EBITDA margin impacted by new hub launch expenses.
- Clinical pregnancy success rate remains strong at 62%.
Price Impact
More from GAUDIUMIVF